Substance Abuse Treatment Market

Market Insights

Substance abuse is the compulsive, excessive, and self-damaging use of habit-forming drugs or substances. Factors such as rising patient awareness, a higher treatment-seeking rate, increased government intervention, a higher number of addicted people, and encouragement to curb substance abuse in all countries are driving the growth of the substance abuse treatment market globally.

The report titled “Substance Abuse Treatment Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall substance abuse treatment market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on drug class and different geographical regions.

In order to help strategic decision-makers, the report also includes sections on the competitive profiling of the leading players in the global substance abuse treatment market, attractive investment propositions, and market positioning of key manufacturers sections.

Geographically, the global substance abuse treatment market is studied for the following regional markets:

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global substance abuse treatment market. Tools such as key player market positioning and appealing investment propositions provide readers with insights into the competitive landscape of the global substance abuse treatment market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global substance abuse treatment market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global substance abuse treatment market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on treatment, the global substance abuse treatment market is segmented as follows:

• Treatment for Alcohol Addiction
• Disulfiram
• Acamprosate
• Naltrexone
• Tobacco and nicotine addiction treatment
• Nicotine Replacement Therapy
• Nicotine Patch
• Nicotine Gum
• Nicotine Lozenges
• Nicotine Spray
• Nicotine Inhaler
• Non-Nicotine Medication
• Bupropion
• Varenicline
• treatment for drug abuse
• Methadone
• Buprenorphine
• Naltrexone

Substance abuse is the compulsive, excessive, and self-damaging use of habit-forming drugs or substances, leading to addiction, dependence, serious physiological injury, psychological harm, or death. Factors such as the alarming rise in the number of substance-addicted populations, the rise in the number of opioid prescriptions written by physicians, increased government intervention, and encouragement to curb substance abuse in all countries are driving the growth of the substance abuse treatment market globally. However, low treatment compliance may negatively impact the growth of the market. In the base year 2016, drug abuse treatment held the largest market share due to factors such as the alarming rise in the number of drug-addicted people, increased government intervention and encouragement to curb substance abuse, and the rise in the number of opioid prescriptions written by physicians, which are driving the growth of the drug abuse treatment market globally.

For the purpose of this study, the global substance abuse treatment market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In the base year 2016, North America dominated the substance abuse treatment market in terms of revenue, and it is anticipated that it will show significant growth during the forecast period. The U.S. was observed as the largest regional market in North America. Factors such as the alarming rise in the number of addicted people, government initiatives in substance abuse prevention and treatment, high awareness about the threats to life and economic burden, and evolved government policies for the same are the prime contributors to the dominance of North America.

Expenditure on healthcare is highest in the U.S. as compared to other nations. It is anticipated that Asia Pacific will grow at the highest CAGR during the forecast period due to the developing economic conditions, an improvement in awareness among the general patient population, improved treatment access, and growing addiction rates, along with a rise in awareness and the evolution of healthcare infrastructure, which will fuel the growth during the forecast period.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Substance Abuse Treatment Market Snapshot
2.2 Global Substance Abuse Treatment Market, by Treatment, 2016 (US$ Bn)
2.3 Global Substance Abuse Treatment Market Share, by Geography, 2016 (Value )

Chapter 3 Substance Abuse Treatment Market Analysis
3.1 Global Substance Abuse Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Higher Number Of Addicted Population
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance In Some Region
3.2.3 Opportunities
3.2.3.1 Increasing Treatment Awareness
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Substance Abuse Treatment Market

Chapter 4 Global Substance Abuse Treatment Market, by Treatment
4.1 Overview
4.2 Alcohol Addiction Treatment
4.3Nicotine Addiction Treatment
4.4 Drug Abuse Treatment

Chapter 5 Global Substance Abuse Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Alkermes Plc.
6.2 Allergan
6.3 Forest Laboratories, Inc.
6.4 GlaxoSmithKline Plc.
6.5 Mylan Laboratories
6.6 Pfizer Inc.
6.7 Purdue Pharma LP
6.8 Reckitt Benckiser Pharmaceuticals
6.9 Teva Pharmaceuticals

List of Figures

FIG. 1 Substance Abuse Treatment Market: Research Methodology
FIG. 2 Global Substance Abuse TreatmentMarket, by Treatment, 2016 (US$ Mn)
FIG. 3 Global Substance Abuse TreatmentMarket, by Geography, 2016 (US$ Mn)
FIG. 4 Attractive Investment Proposition, 2016
FIG. 5 Competitive Analysis of Key Players in Substance Abuse Treatment Market
FIG. 6 Global Disulfiram Market in Alcohol Addiction Treatment, 2015 – 2025 (US$ Mn)
FIG. 7 Global Acamprosate Market in Alcohol Addiction Treatment, 2015 – 2025 (US$ Mn)
FIG. 8 Global Naltrexone Market in Alcohol Addiction Treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Global Nicotine Patch Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Global Nicotine Gum Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Global Nicotine Lozenge Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Global Nicotine Spray Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 13 Global Nicotine Inhaler Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 14 Global Bupropion Market in Non-Nicotine Medication, 2015 – 2025 (US$ Mn )
FIG. 15 Global Varenicline Market in Non-Nicotine Medication, 2015 – 2025 (US$ Mn )
FIG. 16 Global Methadone Market in Drug Abuse Treatment, 2015 – 2025 (US$ Mn)
FIG. 17 Global Buprenorphine Market in Drug Abuse Treatment, 2015 – 2025 (US$ Mn )
FIG. 18 Global Naltrexone Market in Drug Abuse Treatment, 2015 – 2025 (US$ Mn)
FIG. 19 Global Substance Abuse Treatment Market Share Analysis, By Geography, 2016 vs 2025 (Value %)
FIG. 20 North America (U.S., Canada and Mexico): Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 21 U.S. Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 22 Canada Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 23 Europe (Western, Central, Eastern and South Eastern): Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 24 U.K. Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 25 Germany Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 26 Germany: Number of Clients Entering Substance Abuse Treatment, 2010-2013
FIG. 27 Rest of Europe Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 28 Asia: Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 29 China Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 30 Japan Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest of Asia Pacific Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 32 Latin America and Caribbean: Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 33 Latin America Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 34 Africa: Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 35 Middle East and Africa Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Substance Abuse Treatment Market, by Treatment, 2015-2025 (US$ Mn)
TABLE 2 Global Alcohol Addiction Treatment Market, 2015-2025 (US$ Mn)
TABLE 3 Global Nicotine Addiction Treatment Market, 2015-2025 (US$ Mn)
TABLE 4 Global Drug Abuse Treatment Market, 2015-2025 (US$ Mn)
TABLE 5 Global Substance Abuse Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 6 North America Substance Abuse Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 North America Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 8 Europe Substance Abuse Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 10 Asia Pacific Substance Abuse Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 12 Latin America Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 13 Middle East and Africa Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 14 Alkermes Plc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 15 Allergan plc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 17 Mylan N.V.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 18 Pfizer, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 Purdue Pharma LP: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Indivior PLC: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)